The pace of innovation in medicine and health care is accelerating. The first human genome was sequenced at a cost of almost three billion dollars and 13 years. The rapid progress in next generation sequencing has enabled an individual genome to be sequenced at a cost of one thousand dollars in less than three days. Next generation sequencing is transforming disease diagnosis, drug development, and the practice of medicine. This program will explore many of the legal issues raised by the parallel developments of sequencing technology, massive databases of electronic medical records, and bioinformatics. The FDA has begun to change its regulatory approach to laboratory testing and diagnostics, pharmaceutical companies are changing their approach to drug development, and doctors are scrambling to understand and adjust to the changes in science and technology. Anyone interested in the interaction of law and technology or the future of health care is encouraged to attend.
Business meeting at program conclusion.